Possible oscillatory behavior in p53-mdm2 interaction computer simulation

被引：38
|
作者：
Mihalas, GI
Simon, Z
Balea, G
Popa, E
机构：
[1] Univ Med & Pharm, Dept Biophys & Med Informat, Timisoara 1900, Romania
[2] West Univ, Timisoara 1900, Romania
来源：
JOURNAL OF BIOLOGICAL SYSTEMS | 2000年 / 8卷 / 01期
关键词：
computer simulation; interconnected genes; oscillations; p53; mdm2;
D O I：
10.1142/S0218339000000031
中图分类号：
Q [生物科学];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
Specific activator and repressor transcription factors, which bind to specific regulator DNA sequences, play an important role in gene activity control. Interactions between genes coding such transcription factors should explain the different stable or, sometimes, oscillatory gene activities characteristic for different tissues. A set of models has been built for several systems with interconnected genes and the results of the simulations performed for the p53-mdm2 are here presented and discussed.
引用
收藏
页码：21 / 29
页数：9
相关论文
共 50 条
  • [21] Hopf bifurcation analysis for a mathematical model of P53-Mdm2 interaction
    Neamtu, Mihaela
    Horhat, Raul Florin
    Opris, Dumitru
    INTERNATIONAL JOURNAL OF BIFURCATION AND CHAOS, 2008, 18 (01): : 275 - 283
  • [22] Inhibiting the p53-MDM2 interaction:: An important target for cancer therapy
    Chène, P
    NATURE REVIEWS CANCER, 2003, 3 (02) : 102 - 109
  • [23] Medicinal Chemistry Strategies to Disrupt the p53-MDM2/MDMX Interaction
    Lemos, Agostinho
    Leao, Mariana
    Soares, Joana
    Palmeira, Andreia
    Pinto, Madalena
    Saraiva, Lucilia
    Sousa, Maria Emilia
    MEDICINAL RESEARCH REVIEWS, 2016, 36 (05) : 789 - 844
  • [24] Targeting the p53-MDM2 interaction: Synthesis of novel chlorofusin analogs
    Goffin, Sarah Anne
    Howell, Lesley Ann
    Searcey, Mark
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 248
  • [25] Patented inhibitors of p53-Mdm2 interaction (2006-2008)
    Weber, Lutz
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2010, 20 (02) : 179 - 191
  • [26] Mathematical Simulation of p53-Mdm2 Protein Biological System Regulation
    Voropaeva, O. F.
    Shokin, Yu. I.
    Nepomnyashchikh, L. M.
    Senchukova, S. R.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2014, 157 (04) : 535 - 538
  • [27] Relevance of the p53-MDM2 axis to aging
    Wu, Danyi
    Prives, Carol
    CELL DEATH AND DIFFERENTIATION, 2018, 25 (01): : 169 - 179
  • [28] Small molecule inhibitors of the p53-MDM2
    Hu, Chun-Qi
    Hu, Yong-Zhou
    CURRENT MEDICINAL CHEMISTRY, 2008, 15 (17) : 1720 - 1730
  • [29] p53-Mdm2 - the affair that never ends
    Alarcon-Vargas, D
    Ronai, Z
    CARCINOGENESIS, 2002, 23 (04) : 541 - 547
  • [30] Dynamics in the p53-Mdm2 ubiquitination pathway
    Brooks, CL
    Gu, W
    CELL CYCLE, 2004, 3 (07) : 895 - 899
12345